[Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
D000328:Adult; D001201:Ascites / Q000188:drug therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000209:etiology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000209:etiology; D013997:Time Factors; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use*; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use*
D014747:Vinblastine; D003520:Cyclophosphamide; D014228:Triaziquone
Uber die versuchsweise Anwendung einer Kombination von Zytostatika bei fortgeschrittenen Fällen von Ovarialkarzinomen.